Bluesight vs Innoplexus: Revenue, Funding & Team Size Compared
Bluesight generates $60.7M in revenue; Innoplexus generates $62M. Innoplexus and Bluesight are close to the same size by revenue. The table below compares Bluesight and Innoplexus on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $60.7M | $62M |
| Customers | Not disclosed | 200 |
| Team size | 201 | 219 |
| Founded | 2012 | 2011 |
| HQ | Alexandria, United States | Kornwestheim, Germany |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Bluesight at a glance
Bluesight generates $60.7M in revenue with 201 employees, headquartered in Alexandria, United States.
- Revenue
- $60.7M
- Team size
- 201
- Founded
- 2012
Bluesight powers your hospital and pharmacy operations with intelligence that simplifies inventory management, procurement, and compliance. It utilizes AI and machine learning to reduce risks and solve supply chain inefficiencies.
Innoplexus at a glance
Innoplexus generates $62M in revenue with 219 employees, headquartered in Kornwestheim, Germany.
- Revenue
- $62M
- Customers
- 200
- Team size
- 219
- Founded
- 2011
Artificial Intelligence and Blockchain powered solutions for continuous intelligence and real time, relevant insights for Pharmaceutical and Financial Services industry.
Other Bluesight alternatives
Bluesight competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Bluesight vs Innoplexus: frequently asked questions
Is Bluesight or Innoplexus bigger?
Innoplexus is the bigger company by revenue, at $62M against $60.7M for Bluesight.
How much revenue does Bluesight make?
Bluesight generates $60.7M in annual revenue with a team of 201.
How much revenue does Innoplexus make?
Innoplexus generates $62M in annual revenue with a team of 219.